GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Aurobindo Pharma Ltd

Aurobindo Pharma Declares Rs. 7.00 Per Share Interim Dividend for FY27

DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 04 Nov 2026, 08:20 PM IST  ·  BSE ID: a76c1ad6-ae53-44b6-af5d-ec5cb0612e58
View Original BSE Filing (PDF)
💡
In Simple Terms
Aurobindo Pharma's board approved paying shareholders Rs. 7 per share as an interim dividend. November 11, 2026 is the date to identify eligible shareholders.
🤖 AI Summary
  • Aurobindo Pharma declared an interim dividend of Rs. 7.00 per equity share.
  • The dividend payout amounts to 700% of the company's Rs. 1.00 face value equity shares.
  • November 11, 2026, has been fixed as the record date for the dividend.
  • Dividend payments are scheduled to be completed by November 20, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Interim Dividend per Equity Share
Rs. 7.00
Dividend Percentage
700%
Record Date
November 11, 2026
Payment Date
On or before November 20, 2026
🏢 How This Affects the Company
💰
Financial Impact
The interim dividend payment will reduce the company's cash reserves by the total dividend amount. This decision signals a commitment to returning profits to shareholders.
👥 What This Means For Shareholders
✅
Action Required
No action is required by shareholders as the dividend will be automatically credited to their demat accounts.
👤
Who Is Affected
All equity shareholders whose names appear on the company's register of members on November 11, 2026, will receive the dividend.
🔍
Management Signal
The decision signals management's intent to reward shareholders by distributing a portion of the company's profits.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Confirmation of dividend payment by November 20, 2026.
Next quarterly results announcement for FY27.
Future dividend declarations by the Board of Directors.
LOW RISK Routine dividend declaration with clear record and payment dates carries minimal immediate risk.
💡 Investor Takeaway
Aurobindo Pharma announced an interim dividend of Rs. 7.00 per equity share for FY27, with a record date of November 11, 2026, and payment by November 20, 2026.
⚖️ Strengths & Concerns

✅ Positives

  • Declaration of interim dividend of Rs. 7.00 per equity share indicates profitable operations.
  • Confirmed payment timeline for interim dividend by November 20, 2026, provides clarity.
❓ Frequently Asked Questions
What is the interim dividend declared by Aurobindo Pharma for FY 2026-27?
Aurobindo Pharma declared an interim dividend of Rs. 7.00 per equity share, which is 700% of the face value.
When is the record date for Aurobindo Pharma's interim dividend payment?
The record date for the interim dividend payment is November 11, 2026.
By when will Aurobindo Pharma pay the interim dividend for FY 2026-27?
The interim dividend will be paid on or before November 20, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.